Home › Funds › EVOLVE PRIVATE WEALTH, LLC › JNJ

EVOLVE PRIVATE WEALTH, LLC position in JNJ

JOHNSON & JOHNSON · Health Care

EVOLVE PRIVATE WEALTH, LLC reported holding 45,988 shares of JNJ (JOHNSON & JOHNSON) in its Q3 2026 13F filing — a position valued at US$12.2M, representing 0.58% of its reported portfolio and ranking #28 among its reported holdings. EVOLVE PRIVATE WEALTH, LLC has disclosed JNJ holdings in 4 of the last 4 reported quarters, going back to Q4 2025.

Latest position (Q3 2026)45.99K sh
Reported value held$12.17M
Portfolio Weight0.58%
First reportedQ4 2025
Last changeAdd
Updated2026-11-13

Last updated: 2026-11-13 · Source: SEC EDGAR Form 13F-HR

How EVOLVE PRIVATE WEALTH, LLC's JNJ position evolved

EVOLVE PRIVATE WEALTH, LLC first disclosed a stake in JNJ in Q4 2025 at 40,890 shares (US$8.5M). The position peaked in Q3 2026 at 45,988 shares, worth US$12.2M. Across 4 filings, EVOLVE PRIVATE WEALTH, LLC increased the stake 2 time(s), trimmed it 1 time(s) and left it unchanged 0 time(s). The most recent filing (Q3 2026) shows 45,988 shares valued at US$12.2M — an increase of 14,647 shares quarter over quarter.. Notable position changes include a 28% trim in Q2 2026 (shares rose 4% over the following quarter), a 47% increase in Q3 2026 (shares rose 8% over the following quarter).

Quarter by quarter

QuarterSharesValueChange
Q4 2025 40.89K $8.46M New
Q1 2026 43.23K $10.57M Add
Q2 2026 31.34K $7.96M Reduce
Q3 2026 45.99K $12.17M Add

Dots on the line are colored by change type; missing quarters mean no position was reported.

About JNJ and 13F data

JNJ (JOHNSON & JOHNSON) is a Health Care company. 32 other funds we track also report a position in JNJ — the largest reported positions include BlackRock Inc (US$53.87B), Vanguard Group (US$49.74B), VANGUARD CAPITAL MANAGEMENT LLC (US$41.76B). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding JNJ

All JNJ fund holders →

FAQ

How long has EVOLVE PRIVATE WEALTH, LLC held JNJ?

EVOLVE PRIVATE WEALTH, LLC has disclosed JNJ holdings in 4 of the last 4 reported quarters, going back to Q4 2025.

What is EVOLVE PRIVATE WEALTH, LLC's current position in JNJ?

As of Q3 2026, EVOLVE PRIVATE WEALTH, LLC holds 45.99K shares of JNJ (JOHNSON & JOHNSON), valued at $12.17M, representing 0.58% of its reported portfolio and ranking #28.

Has EVOLVE PRIVATE WEALTH, LLC been buying or selling JNJ?

In the latest 13F filing (Q3 2026), EVOLVE PRIVATE WEALTH, LLC increased its position in JNJ. The position peaked in Q3 2026 at 45.99K shares.

Which other funds hold JNJ?

Other major institutional holders of JNJ include BlackRock Inc, Vanguard Group, VANGUARD CAPITAL MANAGEMENT LLC, among 32 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.